Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function.

Hardman C., Chen W., Luo J., Batty P., Chen Y-L., Nahler J., Wu Y., Pavord ID., Erpenbeck VJ., Sandham DA., Xue L., Ogg G.

DOI

10.1016/j.jaci.2019.02.015

Type

Journal article

Journal

The Journal of allergy and clinical immunology

Publication Date

06/2019

Volume

143

Pages

2329 - 2333

Addresses

MRC Human Immunology Unit and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.

Keywords

Lymphocytes, Humans, Indoleacetic Acids, Pyridines, Receptors, Prostaglandin, Receptors, Immunologic, Cytokines, Cell Aggregation, Immunity, Innate

Permalink Original publication